Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4691-4699

  Zheng, Zhi Ming ^a   He, Peijun ^a   Baker, Carl C ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MESSENGER RNA PRECURSOR; VIRUS DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; GENE LOCATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; RNA PROCESSING; RNA SPLICING; SEQUENCE ANALYSIS; SUPPRESSOR GENE; VIRUS GENE; VIRUS PATHOGENESIS;

EID: 0030007649     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4691-4699.1996     Document Type: Article

References (67)

1. Amendt, B. A., D. Hesslein, L.-J. Chang, and C. M. Stoltzfus. 1994. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 14:3960-3970.
2. Amendt, B. A., Z.-H. Si, and C. M. Stoltzfus. 1995. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell. Biol. 15:4606-4615.
3. Baker, C. C. 1990. Bovine papillomavirus type 1 transcription, p. 91-112. In H. Pfister (ed.), Papillomavirus and human cancer. CRC Press, Inc., Boca Raton, Fla.
4. Baker, C. C. 1993. The genomes of the papillomaviruses, p. 1.134-1.146. In S. O'Brien (ed.), Genetic maps: locus maps of complex genomes. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
5. Baker, C. C., and P. M. Howley. 1987. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J. 6:1027-1035.
6. 2443 and late promoters. J. Virol. 67:5605-5616.
7. Barksdale, S. K., and C. C. Baker. 1995. Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs. J. Virol. 69:6553-6556.
8. Berget, S. M. 1995. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:2411-2414.
9. Bouck, J., X.-D. Fu, A. M. Skalka, and R. A. Katz. 1995. Genetic selection for balanced retroviral splicing: novel regulation involving the second step can be mediated by transitions in the polypyrimidine tract. Mol. Cell. Biol. 15:2663-2671.
10. Caputi, M., G. Casari, S. Guenzi, R. Tagliabue, A. Sidoli, C. A. Melo, and F. E. Baralle. 1994. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. Nucleic Acids Res. 22:1018-1022.
11. Del Gatto, F., and R. Breathnach. 1995. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 15:4825-4834.
12. Dirksen, W. P., R. K. Hampson, Q. Sun, and F. M. Rottman. 1994. A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J. Biol. Chem. 269:6431-6436.
13. Freyer, G. A., J. P. O'Brien, and J. Hurwitz. 1989. Alterations in the polypyrimidine sequence affect the in vitro splicing reactions catalyzed by HeLa cell-free preparations. J. Biol. Chem. 264:14631-14637.
14. Fu, X.-D., R. A. Katz, A. M. Skalka, and T. Maniatis. 1991. The role of branchpoint and 3′-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev. 5:211-220.
15. Fu, X.-D., and T. Maniatis. 1992. Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science 256:535-538.
16. Fu, X. Y., H. Ge, and J. L. Manley. 1988. The role of the polypyrimidine stretch at the SV40 early pre-mRNA 3′ splice site in alternative splicing. EMBO J. 7:809-817.
17. Grabowski, P. J., R. A. Padgett, and P. A. Sharp. 1984 Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate. Cell 37:415-427.
18. Helfman, D. M. 1994. The generation of protein isoform diversity by alternative RNA splicing. Soc. Gen. Physiol. Ser. 49:105-115.
19. Helfman, D. M., W. M. Ricci, and L. A. Finn. 1988. Alternative splicing of tropomyosin pre-mRNAs in vitro and in vivo. Genes Dev. 2:1627-1638.
20. Higgins, S. J., and B. D. Harnes. 1994. RNA processing: a practical approach. Oxford University Press, New York.
21. Hodges, D., and S. I. Bernstein. 1994. Genetic and biochemical analysis of alternative RNA splicing. Adv. Genet. 31:207-281.
22. Hoshijima, K., K. Inoue, I. Higuchi, H. Sakamoto, and Y. Shitmura. 1991. Control of doublesex alternative splicing by transformer and transformer-2 in Drosophila. Science 252:833-836.
23. Howley, P. M. 1990. Papillomavirinae and their replication, p. 1625-1650. In B. N. Fields, D. M. Knipe, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and B. Roizman (ed.), Virology. Raven Press, New York.
24. Humphrey, M. B., J. Bryan, T. A. Cooper, and S. M. Berget. 1995. A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol. Cell. Biol. 15:3979-3988.
25. Jamison, S. F., and M. A. Garcia-Blanco. 1992. An ATP-indcpendent U2 small nuclear ribonucleoprotein particle/precursor mRNA complex requires both splice sites and the polypyrimidine tract. Proc. Natl. Acad. Sci. USA 89:5482-5486.
26. Katz, R. A., and A. M. Skalka. 1990. Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol. Cell. Biol. 10:696-704.
27. Kreivi, J.-P., K. Zerivitz, and G. Akusjärvi. 1991. Sequences involved in the control of adenovirus L1 alternative RNA splicing. Nucleic Acids Res. 19:2379-2386.
28. Lambert, P. F., C. C. Baker, and P. M. Howley. 1988. The genetics of bovine papillomavirus type 1. Annu. Rev. Genet. 22:235-258.
29. Lavigueur, A., H. La Branche, A. R. Kornblihtt, and B. Chabot. 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:2405-2417.
30. Lynch, K. W., and T. Maniatis. 1995. Synergistic interactions between two distinct elements of a regulated splicing enhancer. Genes Dev. 9:284-293.
31. McNally, M. T., and K. Beemon. 1992. Intronic sequence and 3′ splice sites control Rous sarcoma virus RNA splicing. J. Virol. 66:6-11.
32. Michaud, S., and R. Reed. 1991. An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev. 5:2534-2546.
33. Nielsen, D. A., and D. J. Shapiro. 1986. Preparation of capped RNA transcripts using T7 RNA polymerase. Nucleic Acids Res. 14:5936.
34. Nilsen, T. W. 1994. RNA-RNA interactions in the spliceosome: unraveling the ties that bind. Cell 78:1-4.
35. Norton, P. A. 1994. Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res. 22:3854-3860.
36. Parker, R., P. G. Siliciano, and C. Guthrie. 1987. Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell 49:229-239.
37. Ramchatesingh, J., A. M. Zahler, K. M. Neugebauer, M. B. Roth, and T. A. Cooper. 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15:4898-4907.
38. Roscigno, R. F., M. Weiner, and M. A. Garcia-Blanco. 1993. A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268:11222-11229.
39. Ruskin, B., P. D. Zamore, and M. R. Green. 1988. A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell 52:207-219.
40. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1992. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
41. Sharp, P. A. 1994. Split genes and RNA splicing. Cell 77:805-816.
42. Siebel, C. W., L. D. Fresco, and D. C. Rio. 1992. The mechanism of somatic inhibition of Drosophila P-element pre-mRNA splicing: multiprotein complexes at an exon pseudo-5′ splice site control U1 snRNP binding. Genes Dev. 6:1386-1401.
43. Staffa, A., and A. Cochrane. 1994. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site. J. Virol. 68:3071-3079.
44. Staffa, A., and A. Cochrane. 1995. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15:4597-4605.
45. Staknis, D., and R. Reed. 1994. SR proteins promote the first specific recognition of pre-mRNA and arc present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14:7670-7682.
46. Staknis, D., and R. Reed. 1994. Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly. Mol. Cell. Biol. 14:2994-3005.
47. Steingrimsdottir, H., G. Rowley, G. Dorado, J. Cole, and A. R. Lehmann. 1992. Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res. 20:1201-1208.
48. Sun, Q., R. K. Hampson, and F. M. Rottman. 1993. In vitro analysis of bovine growth hormone pre-mRNA alternative splicing. Involvement of exon sequences and trans-acting factor(s). J. Biol. Chem. 268:15659-15666.
49. Sun, Q., A. Mayeda, R. K. Hampson, A. R. Krainer, and F. M. Rottman. 1993. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7:2598-2608.
50. Tacke, R., and J. L. Manley. 1995. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14:3540-3551.
51. Tanaka, K., A. Watakabe, and Y. Shimura. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14:1347-1354.
52. Tian, M., and T. Maniatis. 1992. Positive control of pre-mRNA splicing in vitro. Science 256:237-240.
53. Tian, M., and T. Maniatis. 1993. A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell 74:105-114.
54. Tian, M., and T. Maniatis. 1994. A splicing enhancer exhibits both constitutive and regulated activities. Genes Dev. 8:1703-1712.
55. Touchman, J. W., I. D'Souza, C. A. Heckman, R. Zhou, N. W. Biggart, and E. C. Murphy, Jr. 1995. Branchpoint and polypyrimidine tract mutations mediating the loss and partial recovery of the Moloney murine sarcoma virus MuSVts110 thermosensitive splicing phenotype. J. Virol. 69:7724-7733.
56. Watakabe, A., K. Tanaka, and Y. Shimura. 1993. The role of exon sequences in splice site selection. Genes Dev. 7:407-418.
57. Winship, P. R. 1989. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic Acids Res. 17:1266.
58. Wu, J., and J. L. Mauley. 1989. Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev. 3:1553-1561.
59. Xu, R., J. Teng, and T. A. Cooper. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13:3660-3674.
60. Zahler, A. M., K. M. Neugebauer, W. S. Lane, and M. B. Roth. 1993. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260:219-222.
61. Zamore, P. D., and M. R. Green. 1989. Identification, purification, and biochemical characterization of U2 small nuclear ribonucleoprotein auxiliary factor. Proc. Natl. Acad. Sci. USA 86:9243-9247.
62. Zamore, P. D., J. G. Patton, and M. R. Green. 1992. Cloning and domain structure of the mammalian splicing factor U2AF. Nature (London) 355:609-614.
63. Zhang, L., and C. M. Stoltzfus. 1995. A suboptimal src 3′ splice site is necessary for efficient replication of Rous sarcoma virus. Virology 206:1099-1107.
64. Zhao, Q. H., A. Gersappe, and D. J. Pintel. 1995. Efficient excision of the upstream large intron from P4-generated pre-mRNA of the parvovirus minute virus of mice requires at least one donor and the 3′ splice site of the small downstream intron. J. Virol. 69:6170-6179.
65. 64a. Zheng, Z. M., P. J. He, and C. C. Baker. Unpublished results.
66. Zheng, Z. M., P. J. He, D. Caueffield, M. Neumann, S. Specter, C. C. Baker, and M. J. Bankowski. 1995. Enterovirus 71 isolated from China is serologically similar to the prototype E71 BrCr strain but differs in the 5′-noncoding region. J. Med. Virol. 47:161-167.
67. Zhuang, Y., and A. M. Weiner. 1989. A compensatory base change in human U2 snRNA can suppress a branch site mutation. Genes Dev. 3:1545-1552.